Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Voraxaze for Delayed Methotrexate Clearance
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Biomarker/Laboratory analysis, Supportive care, Treatment
Completed
Not specified
Other
2006-0119
NCT00424645
Last Modified:
12/1/1993
2.
Phase I Pilot Pharmacokinetic Study of Carboxypeptidase G2 Rescue of High-Dose MTX in Patients with Recurrent Primary CNS Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Supportive care, Treatment
Completed
18 and over
NCI
MSKCC-93040
NCI-T92-0244D, T92-0244
Last Modified:
5/1/2007
3.
Trial of Carboxypeptidase-G2 for the Management of Patients With Intrathecal Methotrexate Overdose
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Completed
Any age
NCI
NCI-92-C-0137N
CCG-0923, POG-9688, NCI-T92-0021N, COG-0923, COG-P9688, T92-0021, NCT00018967
Last Modified:
3/1/2001
4.
Study of Carboxypeptidase-G2 and Thymidine in Patients With Methotrexate Toxicity Secondary to Renal Dysfunction (Summary Last Modified 03/2001)
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Completed
Any age
NCI
NCI-92-C-0134F
NCI-T92-0022N, T92-0022
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute